United States · Alternative Medicine startup

Elektrofi

Elektrofi is a preclinical-stage company dedicated to redefining the standard of drug delivery by transforming the patient experience.

Funding reportedLast round: Series B

Alternative MedicineBoston, United States

What company datasets say Elektrofi raised

Funding, as reported

Reported in all$112Min dollars
Rounds3
Last roundSeries B
Last round dateJun 2022
Investors listed5
SEC Form D$251M sold, 3 filings, last Oct 2024

Founders and team

From Elektrofi's own website: 5 on the team.

  • Angela HuiVice President, Operations
  • Benjamin EnersonSenior Vice President, Legal and Human Resources
  • Jason MartinSenior Vice President, Technical Operations
  • Lyndon CharlesVice President, Head of Program Management and Strategy
  • Paul BrownVice President, Drug Product Innovation

On a portfolio page

Investors who name them

Each firm lists Elektrofi on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.

Alternative Medicine in United States

Startups like it

Is this your company?

Add your raise, your deck and your story, and put Elektrofi in front of investors. Or tell us what we have wrong.

List your startupSend a correction